Nanosonics Limited (ASX: NAN)

Market Cap	898.50M
Revenue (ttm)	170.01M
Net Income (ttm)	12.97M
Shares Out	303.55M
EPS (ttm)	0.04
PE Ratio	70.48
Forward PE	71.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	211,910
Open	2.950
Previous Close	2.960
Day's Range	2.940 - 2.970
52-Week Range	2.590 - 4.470
Beta	1.55
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 25, 2024

About Nanosonics

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technolo...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 466
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NAN

Financial Performance

In 2024, Nanosonics's revenue was 170.01 million, an increase of 2.42% compared to the previous year's 165.99 million. Earnings were 12.97 million, a decrease of -34.76%.